TNFAIP3, a pivotal negative regulator, has been demonstrated to modulate inflammatory responses by suppressing the NF-κB signaling pathway, a process that is of considerable significance for the pathological progression of COPD [20]. The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.